Cryoviva Singapore uses AXP® II System for processing cord blood samples. This ensures quality in sample processing and results in a higher yield of cell count and viability, resulting in desirable cord blood transplant outcomes. We also abide by the US FDA standards for our storage method using dual cryogenic storage compartment.
Features of AXP® II System
- Highly accurate microprocessors and advanced flow-controlled optical sensors
- Self-powered and fully automated/programmable system with onboard QC function
- Sterile and functionally closed processing bag set system with integrated clot filter and sampling sites
- User friendly XpressTRAK data management system that complies with current good tissue practices (cGTP) and good manufacturing practices (cGMP)
- Compact design and easy scalability
Benefits of AXP® II System
- Provides automation and standardization with high mononucleated cell recovery
- Helps to deliver consistent, reliable, and reproducible results
- Automates blood volume reduction process
- Saves labor costs and reduces human error
- Enables cord blood processing facilities to process various volumes accurately
- Eases blood sampling process and reduces the risk of contamination of final product
- Provides uncompromising safety and quality results
- Allows standardization of the freezing process
- The processing and quality assurance data from every cord blood sample is automatically tracked and fully documented in a quick and accurate manner
- Saves lab space and meets the demand of future growth
Long term cryopreservation system
Our cryopreservation system with in-built battery backup operates flawlessly even without electrical power supply.
It can maintain a temperature of -150 degree Celsius for at least 15 days in the unlikely event of lack of supply of Liquid Nitrogen or any such crisis.
Explant Technology
The Proprietary “Explant Technique” we use is a non-enzymatic method of culturing the tissues, in the most natural condition, to ensure a better yield of highly viable cells for effective therapeutic applications.
We recommend pre-cryostorage cell culture to ensure maximum cell viability, and avoid the post storage tissue loss of the most precious cord tissue MSCs.
This also ensures that the cells are readily available to the family in case of any medical emergency.
Discover the Technology Behind Stem Cell Preservation – Talk to Our Experts
Comparison of Technologies
Please swipe horizontally to view the table
| Method | Cell Count | Cell Visibility | Cell Potency | |
|---|---|---|---|---|
|
Explant Method |
Akin to natural cell proliferation |
Higher yield per cm of Umbilical Cord |
Better viability |
Cells with highest regeneration potential proliferate |
|
Enzymatic Method |
Chemicals used – artificial process |
5 to 10 times lower yield |
Viability compromised as cell surface damage is possible |
Cells with lower regeneration potential |
FAQ's
Cord Blood is the blood left in the baby’s Umbilical Cord after birth, rich in Stem Cells used for treating blood and immune disorders.
Cryoviva Singapore uses the AXP® II System, an automated platform designed to provide consistent, high-quality processing with minimal manual handling.
The system enhances mononuclear cell recovery, reduces human error, and ensures reproducible results through automation and precise optical sensors.
Yes. The AXP® II System uses a closed, sterile setup that helps reduce contamination risks and supports more reliable cord blood processing outcomes.
Cryoviva’s long-term cryopreservation system has an in-built battery backup and maintains temperatures of around -150°C, even during unexpected power or supply interruptions.
Maintaining temperatures below -150°C helps preserve cell viability for long-term storage, ensuring the sample remains usable if needed in the future.
AXP® II uses a closed-system automated method that minimizes contamination and ensures consistent cell recovery.
Because it provides cleaner, precise, and standardized stem cell separation, improving the safety of long-term storage.
